title: Does immunosuppressive therapy influence the recovery of bone disease in kidney transplant recipients?
authors.affiliation: Department of Nephrology, Hospital de Bellvitge, Barcelona, Spain.
authors.forename: M T
authors.initials: MT
authors.lastname: Gonzalez
authors.forename: C
authors.initials: C
authors.lastname: Gonzalez
authors.forename: J
authors.initials: J
authors.lastname: Bover
authors.forename: R
authors.initials: R
authors.lastname: Bonnin
authors.forename: M L
authors.initials: ML
authors.lastname: Mariñoso
authors.forename: S
authors.initials: S
authors.lastname: Serrano
authors.forename: A M
authors.initials: AM
authors.lastname: Castelao
authors.forename: J M
authors.initials: JM
authors.lastname: Griño
authors.forename: J
authors.initials: J
authors.lastname: Alsina
mesh_terms: D000328:Adult; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002114:Calcinosis / Q000209:etiology; D002117:Calcitriol / Q000627:therapeutic use; D002118:Calcium / Q000097:blood; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D006801:Humans; D006961:Hyperparathyroidism / Q000209:etiology / Q000628:therapy*; D007165:Immunosuppression Therapy; D007676:Kidney Failure, Chronic / Q000503:physiopathology* / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D013256:Steroids / Q000627:therapeutic use
chemical_list: D013256:Steroids; D000536:Aluminum Hydroxide; D016572:Cyclosporine; D002117:Calcitriol; D001379:Azathioprine; D002118:Calcium